Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI

JNJ•2026-10-29

A model projects lower lifetime healthcare costs and better quality-adjusted survival with Impella heart pumps than with intra-aortic balloon pumps for heart failure patients undergoing high-risk PCI. Johnson & Johnson plans to present 26 Impella abstracts at TCT 2026, Oct. 31-Nov. 3 in San Diego.

1. Model projections

2. TCT presentations

Johnson & Johnson will present 26 Impella heart pump abstracts at TCT 2026, running Oct. 31-Nov. 3 in San Diego.

Sources

Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI

Publicnow

Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI

1. Model projections

2. TCT presentations

Related News

Caterpillar tops quarterly profit view, but unchanged growth target dents shares

C.H. Robinson Worldwide target price cut to $204 from $230

Nasdaq trade halt: volatility trading pause at 09:32 am

Sources

Johnson & Johnson model projects lower lifetime costs with Impella versus balloon pump in high-risk PCI

Bunge beats quarterly profit estimates on strong crush margins

DoorDash strikes $17 billion deal for US rival Instacart in mega grocery delivery bet